Fact.MR, in its latest research, anticipates the global kidney cancer diagnostics market to witness an impressive expansion at a CAGR of 6.4% over the forecast period 2017 to 2022. Tremendous transformations have been witnessed over the recent past, in the management and diagnosis of renal cell carcinoma (RCC), or, kidney cancer. Numerous discoveries, trails, and studies ... Read more